AUGUSTA, ME – Patients diagnosed with post-traumatic stress, Crohn’s disease, and other debilitating disorders will soon be eligible for cannabis therapy underlegislation approved last week absent the Governor’s signature.
Survey data published in 2011 in the European Journal of Gastroenterology and Hepatology reported that the use of cannabis therapy is common among patients with inflammatory bowel disorders.
Five of the eleven patients in the study group also reported achieving disease remission (defined as a reduction in patient CDAI score by more than 150 points).